Market Value441,891,839
Total Holdings46
File Date2026-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
RGEN / Repligen Corporation
PVLA / Palvella Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
NTRA / Natera, Inc.
AKTS / Aktis Oncology, Inc.
CATX / Perspective Therapeutics, Inc.
CORT / Corcept Therapeutics Incorporated
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
ELVN / Enliven Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
ABUS / Arbutus Biopharma Corporation
ORKA / Oruka Therapeutics, Inc.
BBOT / BridgeBio Oncology Therapeutics, Inc.
AVR / Anteris Technologies Global Corp.
KPTI / Karyopharm Therapeutics Inc.
DXCM / DexCom, Inc.
CNTX / Context Therapeutics Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
MDT / Medtronic plc
YBO0 / Tenax Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
TEM / Tempus AI, Inc.
ACHC / Acadia Healthcare Company, Inc.
A / Agilent Technologies, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
COR / Cencora, Inc.
DHR / Danaher Corporation
HQY / HealthEquity, Inc.
INSM / Insmed Incorporated
ITGR / Integer Holdings Corporation
IQV / IQVIA Holdings Inc.
ABT / Abbott Laboratories
NTLA / Intellia Therapeutics, Inc.
BSX / Boston Scientific Corporation
BBIO / BridgeBio Pharma, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
MLTX / MoonLake Immunotherapeutics
SCYX / SCYNEXIS, Inc.
HUM / Humana Inc.
EHC / Encompass Health Corporation
IMUX / Immunic, Inc.
PODD / Insulet Corporation
ICLR / ICON Public Limited Company
SVRA / Savara Inc.
CRL / Charles River Laboratories International, Inc.
GILD / Gilead Sciences, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
MSLE / Satellos Bioscience Inc.
ODD / Oddity Tech Ltd.
PTON / Peloton Interactive, Inc.
JBIO / Jade Biosciences, Inc.
HIMS / Hims & Hers Health, Inc.
MCK / McKesson Corporation
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
PFE / Pfizer Inc.
CI / The Cigna Group
TMO / Thermo Fisher Scientific Inc.
WAT / Waters Corporation
PHAT / Phathom Pharmaceuticals, Inc.
TRVI / Trevi Therapeutics, Inc.